IVF with PGT-A in Spain: Advanced Genetic Screening for Successful Pregnancy at UR Vistahermosa Alicante
Navigating the complexities of infertility can be an overwhelming journey, but modern reproductive medicine offers unprecedented hope through IVF with PGT-A in Spain. For couples facing recurrent pregnancy loss, repeated implantation failures, or advanced maternal age, standard In Vitro Fertilization often leaves critical variables to chance. Preimplantation Genetic Testing for Aneuploidies (PGT-A) removes the guesswork by thoroughly screening embryos for chromosomal abnormalities prior to transfer.
By choosing advanced genetic screening for successful pregnancy at UR Vistahermosa Alicante, international patients gain access to world-class laboratory technology, elite embryologists, and a progressive legal framework. Watch to discover how this advanced genetic profiling dramatically increases the likelihood of a healthy, full-term pregnancy while reducing the emotional and financial toll of unsuccessful fertility cycles.
Video Chapters & Quick Navigation
Understanding IVF with PGT-A in Spain
In Vitro Fertilization (IVF) has revolutionized the way we approach human reproduction, allowing millions of individuals to build families. However, creating an embryo in a laboratory setting does not guarantee a successful pregnancy. This is where Preimplantation Genetic Testing for Aneuploidies (PGT-A) becomes an indispensable tool for modern fertility specialists.
PGT-A is a highly sophisticated genetic screening technique performed on embryos created through IVF before they are transferred into the patient's uterus. The primary goal of this procedure is to verify that the embryo possesses the exact correct number of chromosomes. Human biology dictates that a healthy embryo must have 46 chromosomes—23 inherited from the biological mother and 23 from the biological father.
When an embryo has an incorrect number of chromosomes, a condition known as aneuploidy occurs. Aneuploid embryos are the leading cause of failed IVF implantations and early first-trimester miscarriages. By meticulously analyzing the genetic makeup of each embryo, the specialists at UR Vistahermosa in Alicante can confidently select only euploid (chromosomally normal) embryos for transfer, dramatically optimizing the entire fertility treatment cycle.
The Critical Role of Chromosomal Health in Pregnancy
To fully grasp the magnitude of advanced genetic screening for successful pregnancy, patients must understand how chromosomal health directly impacts gestation. Chromosomal abnormalities are entirely natural and surprisingly common, even among young, healthy couples. However, the incidence of these abnormalities increases exponentially as maternal age advances.
An embryo with a missing chromosome (monosomy) or an extra chromosome (trisomy) will almost always fail to implant in the uterine lining. If implantation does occur, the pregnancy typically results in an early miscarriage. In some instances, aneuploid embryos may develop into pregnancies that carry to term but result in severe genetic conditions, such as Down syndrome (Trisomy 21), Edwards syndrome (Trisomy 18), or Patau syndrome (Trisomy 13).
The emotional devastation of a failed IVF cycle or a miscarriage cannot be overstated. Standard morphological grading—where an embryologist looks at the embryo under a microscope to evaluate its physical appearance—cannot detect these hidden genetic errors. A beautiful, highly graded blastocyst can still be chromosomally abnormal. PGT-A bridges this critical diagnostic gap, providing cellular-level insights that standard observation simply cannot achieve.
How Aneuploidy Rates Shift with Age
Maternal age remains the single most significant factor influencing egg quality and subsequent embryo genetics. A woman is born with all the eggs she will ever have, and as she ages, the cellular machinery responsible for dividing chromosomes becomes less efficient.
For women in their late twenties, roughly 25% to 30% of their embryos may be aneuploid. By the time a woman reaches the age of 40, up to 70% or more of her embryos may contain chromosomal abnormalities. This stark biological reality underscores why advanced maternal age is a primary indicator for utilizing PGT-A during fertility treatments abroad.
Why Choose UR Vistahermosa Alicante for Advanced Fertility Treatments?
Spain has firmly established itself as the premier destination for reproductive tourism in Europe, and UR Vistahermosa in Alicante stands at the vanguard of this medical excellence. What distinguishes this clinic is not merely its impressive success rates, but its structural integration within a major multidisciplinary medical facility.
Located inside the prestigious HLA Vistahermosa hospital complex, the fertility unit operates with the full backing of advanced medical infrastructure. This integration provides an unparalleled layer of safety and comprehensive care for international patients. If any medical complications arise during ovarian stimulation or egg retrieval, patients are already inside a fully equipped hospital, surrounded by specialized medical teams.
Furthermore, UR Vistahermosa houses one of the most advanced embryology laboratories in Europe. The precision required for PGT-A is immense. The laboratory utilizes state-of-the-art Next Generation Sequencing (NGS) technology, which offers the highest resolution available for analyzing embryonic DNA. This cutting-edge equipment, operated by highly trained geneticists and embryologists, ensures that the genetic screening process is both exceptionally accurate and safe for the developing embryos.
Who Should Consider PGT-A During Their IVF Journey?
While PGT-A offers profound benefits, fertility specialists tailor its application to patients who will gain the most significant clinical advantage. During initial consultations at UR Vistahermosa, the medical team carefully evaluates each patient's unique reproductive history to determine if preimplantation genetic testing for aneuploidies is the correct therapeutic pathway.
The most compelling indications for incorporating genetic testing into an IVF cycle include a variety of complex fertility challenges. Below are the primary patient profiles that benefit most from this advanced diagnostic tool:
- Advanced Maternal Age: Women aged 38 and older experience a naturally higher rate of chromosomal errors in their oocytes. PGT-A helps identify the viable embryos amidst a higher percentage of aneuploid ones.
- Recurrent Pregnancy Loss: Couples who have suffered two or more unexplained miscarriages often discover that underlying chromosomal abnormalities are the root cause. Screening embryos prevents the transfer of those destined to miscarry.
- Repeated Implantation Failure: If a patient has undergone multiple IVF cycles with the transfer of good-quality embryos that failed to implant, PGT-A can determine if genetic factors are to blame.
- Severe Male Factor Infertility: Extreme cases of poor sperm morphology or low sperm count can also contribute to an increased risk of embryo aneuploidy, making genetic screening highly advisable.
The Step-by-Step PGT-A Biopsy Process at UR Vistahermosa
The procedure for IVF with PGT-A in Spain involves a meticulously choreographed sequence of medical and laboratory events. The journey begins much like a standard IVF cycle, with the administration of hormonal medications to stimulate the ovaries to produce multiple mature follicles.
1. Ovarian Stimulation and Egg Retrieval
Following careful ultrasound monitoring, the eggs are retrieved through a minimally invasive, ultrasound-guided transvaginal aspiration procedure. This is performed under light sedation to ensure complete patient comfort. Once retrieved, the eggs are immediately transferred to the adjoining high-tech embryology laboratory.
2. Fertilization via ICSI
To maximize fertilization rates and prevent genetic contamination from extraneous sperm during the biopsy process, Intracytoplasmic Sperm Injection (ICSI) is exclusively used. A single, morphologically optimal sperm is selected and injected directly into the center of each mature egg.
3. Blastocyst Culturing and Trophectoderm Biopsy
The fertilized eggs are placed in advanced time-lapse incubators where they are cultured for five to six days. The goal is for the embryos to reach the blastocyst stage, which consists of over 100 cells. At this stage, the embryo has differentiated into two parts: the inner cell mass (which becomes the fetus) and the trophectoderm (which becomes the placenta).
A highly skilled embryologist uses a precision laser to safely extract 3 to 5 cells from the trophectoderm. Because these cells are destined to become the placenta, the delicate inner cell mass remains completely untouched and unharmed. This targeted trophectoderm biopsy is the safest and most reliable method for genetic testing.
4. Cryopreservation and Genetic Sequencing
Immediately following the biopsy, the blastocysts are safely cryopreserved (frozen) using an ultra-rapid cooling technique called vitrification. The extracted cells are sent to the genetics laboratory for Next Generation Sequencing. Once the genetic report is finalized—usually within two to three weeks—the medical team will plan a frozen embryo transfer (FET) using a definitively euploid embryo.
Advantages of Seeking IVF Treatments in Spain
Spain is legally and culturally positioned as a global hub for reproductive medicine. The Spanish Assisted Reproduction Law is widely considered one of the most progressive and comprehensive legal frameworks in the world. This legislation protects the rights of patients while allowing access to advanced scientific techniques that are heavily restricted or entirely banned in other countries.
Unlike the United Kingdom or Germany, where certain reproductive technologies face strict legal hurdles, Spain fully permits and regulates PGT-A for the optimization of IVF outcomes. This regulatory freedom allows clinics like UR Vistahermosa Alicante to push the boundaries of medical innovation, applying the latest genetic science to solve complex infertility cases without bureaucratic interference.
Cost efficiency is another major driver for international medical tourism. The cost of IVF with PGT-A in Spain is substantially lower than comparable treatments in the United States, Canada, or the UK. Patients can often expect to save between 40% to 60% on their overall treatment costs, even when factoring in flights and luxury accommodations. This affordability does not come at the expense of quality; rather, it reflects a different healthcare economic structure that heavily subsidizes medical infrastructure and education.
Comparing IVF Success Rates: With and Without Genetic Screening
The clinical data surrounding advanced genetic screening for successful pregnancy is overwhelmingly positive. By eliminating embryos destined to fail from the transfer queue, the clinical pregnancy rate per transfer skyrockets. Furthermore, the time it takes to achieve a successful pregnancy is drastically reduced, sparing patients the physical and emotional exhaustion of multiple failed cycles.
At top-tier clinics like UR Vistahermosa, the difference in outcomes is stark. Single Embryo Transfer (SET) is highly encouraged when using a PGT-A tested embryo, which virtually eliminates the high risks associated with multiple pregnancies (twins or triplets) while maintaining exceptional success rates.
| Treatment Factor | Standard IVF (Untested Embryos) | IVF + PGT-A (Euploid Embryos) |
|---|---|---|
| Implantation Rate | Varies wildly by age (20% - 45%) | Consistently High (60% - 70%+) |
| Miscarriage Rate | Increases with age (up to 50%+) | Dramatically Reduced (Under 10%) |
| Time to Pregnancy | Often requires multiple transfers | Significantly accelerated timeline |
| Risk of Genetic Disease | Standard baseline risk | Virtually eliminated for aneuploidies |
Combining Egg Donation with PGT-A in Alicante
For patients who are unable to use their own oocytes due to diminished ovarian reserve or premature ovarian failure, UR Vistahermosa operates an exceptionally robust and highly regulated egg donation program. Spain is renowned for its entirely anonymous and strictly altruistic gamete donation laws, resulting in one of the largest and most diverse donor pools in Europe.
Donors undergo rigorous psychological, physical, and genetic screening before being accepted into the program. While donor eggs come from young, healthy women (typically under the age of 30) where the risk of chromosomal abnormalities is naturally low, some couples still opt to combine donor egg IVF with PGT-A.
This dual approach provides the absolute highest tier of certainty. By securing high-quality donor eggs and then verifying the chromosomal integrity of the resulting embryos, patients can achieve implantation rates that represent the pinnacle of modern reproductive medicine.
Navigating the Medical Tourism Experience in Alicante
Embarking on a journey for fertility treatments abroad can initially seem daunting, but specialized international departments are designed to make the process completely seamless. UR Vistahermosa boasts a dedicated international patient care team that coordinates every aspect of the medical journey. From remote video consultations to translating medical records and scheduling precise protocol timelines, the logistical burden is entirely lifted from the patient's shoulders.
Alicante itself serves as a therapeutic backdrop for this profoundly personal medical journey. Situated on Spain's stunning Costa Blanca, the city offers a tranquil, sun-drenched environment that actively promotes relaxation and stress reduction. High levels of cortisol and stress are known antagonists to reproductive success. Escaping the pressures of daily life to recover in a serene Mediterranean coastal city provides an invaluable psychological benefit during the critical phases of embryo transfer and the subsequent two-week wait.
Patients have access to all-inclusive concierge services through medical tourism facilitators, ensuring that accommodations, airport transfers, and clinic transportation are flawlessly executed. The focus remains entirely where it should be: on the patient's health, peace of mind, and the ultimate goal of achieving a successful, healthy pregnancy through the safest, most scientifically advanced methods available today.
Take the Next Step Toward Your Family’s Future
Are you ready to stop leaving your fertility journey to chance? Discover how the world-class specialists at UR Vistahermosa in Spain can use advanced PGT-A genetic screening to help you achieve a successful, healthy pregnancy. Connect with PlacidWay Medical Tourism today to begin your personalized consultation.
GET A FREE CONSULTATION & QUOTE
Share this listing